Breaking News

You are here » Indian-Commodity  :  Corporate  :  Aurobindo Pharma reports 12% fall in Q1 consolidated net profit

10-Aug2018

Aurobindo Pharma reports 12% fall in Q1 consolidated net profit

Aurobindo Pharma has reported results for first quarter ended June 30, 2018.

The company has reported a fall of 26.75% in its net profit at Rs 225.12 crore for the quarter under review as compared to Rs 307.33 crore for the same quarter in the previous year. However, total income of the company increased by 16.44% at Rs 2,561.64 crore for Q1FY19 as compared Rs 2,199.96 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 12.12% in its net profit at Rs 455.66 crore for the quarter under review as compared to Rs 518.51 crore for the same quarter in the previous year. However, total income of the company increased by 16.03% at Rs 4,294.00 crore for Q1FY19 as compared Rs 3,700.84 crore for the corresponding quarter previous year.


Related News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......